Unlock Your
Potential With
Ketamine Therapy
for Anxiety

Your anxiety breakthrough awaits. Mindbloom’s clinician-prescribed, science-backed psychedelic therapy often leads to rapid, meaningful results after your initial sessions. Our world-class clinical team will help make sure it’s right for you. ‍

Benefits of Impact Psychedelics for
Anxiety Treatment

01

Safe

Since 1970, Ketamine has been an FDA-approved anesthetic, and it is well-tolerated with patients ranging from young children to seniors. 

It’s now used safely as an off-label prescription to treat anxiety, as well as depression, PTSD, OCD, and other mental health-related diagnoses.

Since 1970, Ketamine has been an FDA-approved anesthetic, and it is well-tolerated with patients ranging from young children to seniors. 

It’s now used safely as an off-label prescription to treat anxiety, as well as depression, PTSD, OCD, and other mental health-related diagnoses.

Ketamine is the only clinician-prescribed psychedelic medicine. Impact’s licensed psychiatric clinicians are qualified to diagnose mental health conditions, prescribe appropriate medications, and facilitate positive therapeutic experiences using ketamine as a treatment for anxiety and depression.

After completing their initial four-session programs, Impact’s clients with anxiety or depression report improvement in symptoms over 85% of the time. Our therapeutic programs can achieve rapid and lasting mental health benefits

Impact Psychedelics’s ketamine therapy is fully virtual! Enjoy your therapeutic journey in comfort and safety wherever you are, monitored by a loved one or close friend. Our expert psychedelic medicine guides and clinicians assist you every step of the way.

02

Legal

Ketamine is the only clinician-prescribed psychedelic medicine. Impact’s licensed psychiatric clinicians are qualified to diagnose mental health conditions, prescribe appropriate medications, and facilitate positive therapeutic experiences using ketamine as a treatment for anxiety and depression.

03

Effective

After completing their initial four-session programs, Impact’s clients with anxiety or depression report improvement in symptoms over 85% of the time. Our therapeutic programs can achieve rapid and lasting mental health benefits

04

Convenient

Impact Psychedelics’s ketamine therapy is fully virtual! Enjoy your therapeutic journey in comfort and safety wherever you are, monitored by a loved one or close friend. Our expert psychedelic medicine guides and clinicians assist you every step of the way.

Please review the important safety information on our website for more information about the potential risks and side effects of ketamine

Why Ketamine is Effective for Anxiety Treatment

It’s Rapidly Effective

Ketamine’s benefits often begin to appear within hours, and clinical trials with intravenous ketamine have shown peak mood elevation about 24-36 hours after treatment.

You Don’t Have to Take it Every Day

Unlike other psychiatric medications that are typically taken daily, ketamine treatments are far less frequent. Our clients often begin by taking medication weekly during their initial program and then increase the duration between treatments in subsequent programs.

Ketamine’s benefits often begin to appear within hours, and clinical trials with intravenous ketamine have shown peak mood elevation about 24-36 hours after treatment.

Unlike other psychiatric medications that are typically taken daily, ketamine treatments are far less frequent. Our clients often begin by taking medication weekly during their initial program and then increase the duration between treatments in subsequent programs.

The biological and neurochemical basis of ketamine creates a fertile brain state for making powerful, positive changes in your life. Ketamine helps release BDNF (brain-derived neurotrophic factor), which helps promote the growth, maintenance, and survival of neurons, enhancing neuroplasticity.

The actions and behaviors you take can be received more fully, and settle in more naturally, through the neuroplastic state ketamine induces.

It can promote awareness for new perspectives with enhanced neuroplasticity

The biological and neurochemical basis of ketamine creates a fertile brain state for making powerful, positive changes in your life. Ketamine helps release BDNF (brain-derived neurotrophic factor), which helps promote the growth, maintenance, and survival of neurons, enhancing neuroplasticity.

The actions and behaviors you take can be received more fully, and settle in more naturally, through the neuroplastic state ketamine induces.

REVIEWS

Hear from Our Clients

A RECENT EXPERIENCE

"I was really struggling with ruminating anxiety despite psychotherapy. My clinician Stephanie made me feel comfortable... and the experience blew my mind. I’m finally out of the rut I was in for several years. I LOVE that feeling."

Jonathan S. - healthcare provider in Phoenix, Arizona

We know that ketamine modulates additional receptor types, but the glutamate receptors seem to play the most important role in ketamine’s ability to treat depression and anxiety.

‍Neurons have a number of different binding sites for glutamate, but when it comes to ketamine, two are of particular interest: the NMDA receptor and the AMPA receptor.

‍By increasing the level of glutamate transmission while also shifting the balance of glutamate activation from NMDA to AMPA receptors, ketamine rapidly upregulates neuronal production and release of BDNF (brain-derived neurotrophic factor). Aptly called fertilizer for the brain, BDNF is a protein that helps promote the growth, maintenance, and survival of neurons—in other words, it enhances neuroplasticity.

The answer is often yes. Each person’s health profile is unique, and during your video consultation, a clinician will work with you to determine the best treatment plan based on your evaluation and health history. Some medications are contraindicated with ketamine, so please be sure to walk through your current medications with your clinician.

‍Some Impact clients have been able to safely taper off their anti-anxiety or antidepressant medications under the close supervision of their existing psychiatric providers, following improvements from ketamine therapy.

In addition to ketamine for anxiety, ketamine therapy is backed by research and used by Impact to treat depression. 

‍Ketamine has also been used successfully to treat post-traumatic stress disorder (PTSD), OCD, chronic pain, and is an emerging treatment for other diagnoses.

Ketamine therapy has an excellent safety record.

‍Impact Psychedelics’s clinical team and board of expert advisors have decades of experience in psychiatry, psychedelic research, and ketamine treatment. The clinical protocols that they’ve implemented ensure that we’re providing safe and science-backed treatment for all of our clients.

Our expert clinicians are licensed, and Impact Guides are equipped with experience and training to lead you safely through the entirety of your psychedelic therapy experience.

‍Impact has helped hundreds of clients achieve positive outcomes through ketamine therapy.

Using ketamine for depression treatment is 100% legal.

‍Currently, ketamine is the only legally prescribable psychedelic medicine available, and is available for off-label use for diagnoses like depression. Ketamine prescriptions are given exclusively through Impact Psychedelics’s licensed clinicians.

‍Learn more about the psychedelic medicine pipeline, and current clinical trials leading to advancements in the field of psychedelic therapy.

FAQ

We know that ketamine modulates additional receptor types, but the glutamate receptors seem to play the most important role in ketamine’s ability to treat depression and anxiety.

‍Neurons have a number of different binding sites for glutamate, but when it comes to ketamine, two are of particular interest: the NMDA receptor and the AMPA receptor.

‍By increasing the level of glutamate transmission while also shifting the balance of glutamate activation from NMDA to AMPA receptors, ketamine rapidly upregulates neuronal production and release of BDNF (brain-derived neurotrophic factor). Aptly called fertilizer for the brain, BDNF is a protein that helps promote the growth, maintenance, and survival of neurons—in other words, it enhances neuroplasticity.

The answer is often yes. Each person’s health profile is unique, and during your video consultation, a clinician will work with you to determine the best treatment plan based on your evaluation and health history. Some medications are contraindicated with ketamine, so please be sure to walk through your current medications with your clinician.

‍Some Impact clients have been able to safely taper off their anti-anxiety or antidepressant medications under the close supervision of their existing psychiatric providers, following improvements from ketamine therapy.

In addition to ketamine for anxiety, ketamine therapy is backed by research and used by Impact to treat depression. 

‍Ketamine has also been used successfully to treat post-traumatic stress disorder (PTSD), OCD, chronic pain, and is an emerging treatment for other diagnoses.

Ketamine therapy has an excellent safety record.

‍Impact Psychedelics’s clinical team and board of expert advisors have decades of experience in psychiatry, psychedelic research, and ketamine treatment. The clinical protocols that they’ve implemented ensure that we’re providing safe and science-backed treatment for all of our clients.

Our expert clinicians are licensed, and Impact Guides are equipped with experience and training to lead you safely through the entirety of your psychedelic therapy experience.

‍Impact has helped hundreds of clients achieve positive outcomes through ketamine therapy.

Using ketamine for depression treatment is 100% legal.

‍Currently, ketamine is the only legally prescribable psychedelic medicine available, and is available for off-label use for diagnoses like depression. Ketamine prescriptions are given exclusively through Impact Psychedelics’s licensed clinicians.

‍Learn more about the psychedelic medicine pipeline, and current clinical trials leading to advancements in the field of psychedelic therapy.